Ingredion Inc. (INGR)
UK's Tate & Lyle agrees $3.6 billion Ingredion takeover
Britain's Tate & Lyle has agreed to a £2.7 billion ($3.60 billion) offer from U.S. rival Ingredion , the companies said on Monday, creating a food and beverage ingredients major.
Ingredion Takeover Target Tate & Lyle Posts Fall in Profit
The British ingredients company reported lower profit for what it called a disappointing fiscal year.
Ingredion: Oversold After Argo Issues, Acquisition Could Change The Story
Ingredion Incorporated (INGR) remains a Buy, supported by strong financials and robust cash generation despite recent operational setbacks and macro pressures. Q1 results were weak due to Argo facility issues, leading to reduced 2026 guidance and highlighting operational and cost risks. Potential acquisition of Tate & Lyle could transform INGR, expanding geographic reach significantly and helping to diversify into higher-growth segments.
Tate & Lyle In Talks With Ingredion Over $3.7 billion Takeover Offer
The proposed offer value is a 64% premium to the London-listed food-and-beverage ingredient company's closing share price Wednesday.
Ingredion Q1 Earnings Call Highlights
Ingredion NYSE: INGR reported a weaker-than-expected first quarter of 2026, as operational problems at its Argo facility weighed heavily on results in its Food & Industrial Ingredients U.S. Canada segment, while its Texture & Healthful Solutions business continued to post volume growth.
Ingredion Incorporated (INGR) Q1 2026 Earnings Call Transcript
Ingredion Incorporated (INGR) Q1 2026 Earnings Call Transcript
Ingredion (INGR) Lags Q1 Earnings Estimates
Ingredion (INGR) came out with quarterly earnings of $2.34 per share, missing the Zacks Consensus Estimate of $2.44 per share. This compares to earnings of $2.97 per share a year ago.
Earnings Preview: Ingredion (INGR) Q1 Earnings Expected to Decline
Ingredion (INGR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ingredion Incorporated (INGR) Presents at Consumer Analyst Group of New York Conference 2026 Prepared Remarks Transcript
Ingredion Incorporated (INGR) Presents at Consumer Analyst Group of New York Conference 2026 Prepared Remarks Transcript
Ingredion: Defensive, High-Yield, Undervalued, And Transforming For Growth
Ingredion is reiterated as a Buy, supported by strong financial health and robust free cash flow exceeding guidance. INGR advances strategic pillars—protein and clean label ingredients—while completing its Cost2Compete program, achieving $59M in run-rate savings. 2026 guidance calls for low- to mid-single-digit net sales growth, EPS of $11–$11.80, and free cash flow midpoint of $460M.
Ingredion Q4: Poised For Lackluster First Half, But It Is Getting Interesting
Ingredion Incorporated delivered resilient profitability and has a strong balance sheet despite flat sales and US/Canada production setbacks. INGR guidance for 2024 is cautious: EPS of $11.00-$11.80, low-to-mid single-digit sales growth, and modest operating income improvement. Operational efficiency initiatives and R&D focus on Clean Labels and plant-based ingredients position INGR for future margin expansion.
Ingredion (INGR) Misses Q4 Earnings and Revenue Estimates
Ingredion (INGR) came out with quarterly earnings of $2.53 per share, missing the Zacks Consensus Estimate of $2.59 per share. This compares to earnings of $2.63 per share a year ago.
